Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 02, 2022

SELL
$277.25 - $366.29 $1.28 Million - $1.7 Million
-4,633 Closed
0 $0
Q4 2021

Feb 23, 2022

BUY
$300.63 - $371.35 $1.2 Million - $1.48 Million
3,988 Added 618.29%
4,633 $1.66 Million
Q3 2021

Oct 28, 2021

SELL
$310.19 - $376.2 $131,210 - $159,132
-423 Reduced 39.61%
645 $201,000
Q2 2021

Aug 12, 2021

SELL
$262.71 - $351.17 $562,987 - $752,557
-2,143 Reduced 66.74%
1,068 $333,000
Q1 2021

Apr 26, 2021

SELL
$285.92 - $355.13 $3.67 Million - $4.56 Million
-12,841 Reduced 80.0%
3,211 $1.02 Million
Q4 2020

Feb 02, 2021

BUY
$251.88 - $324.2 $1.69 Million - $2.17 Million
6,698 Added 71.61%
16,052 $5.2 Million
Q3 2020

Oct 14, 2020

BUY
$255.22 - $317.0 $572,203 - $710,714
2,242 Added 31.52%
9,354 $2.59 Million
Q2 2020

Jul 13, 2020

BUY
$141.4 - $257.09 $324,088 - $589,250
2,292 Added 47.55%
7,112 $1.72 Million
Q1 2020

Apr 29, 2020

BUY
$130.51 - $196.01 $629,058 - $944,768
4,820 New
4,820 $699,000
Q4 2019

Feb 05, 2020

SELL
$159.31 - $223.54 $1.33 Million - $1.87 Million
-8,374 Closed
0 $0
Q3 2019

Oct 15, 2019

BUY
$175.89 - $279.23 $269,111 - $427,221
1,530 Added 22.36%
8,374 $1.49 Million
Q2 2019

Jul 26, 2019

BUY
$250.96 - $284.94 $1.72 Million - $1.95 Million
6,844 New
6,844 $1.78 Million
Q4 2018

Jan 16, 2019

SELL
$281.08 - $444.25 $5.98 Million - $9.45 Million
-21,279 Closed
0 $0
Q3 2018

Oct 23, 2018

BUY
$354.53 - $449.75 $1.71 Million - $2.17 Million
4,815 Added 29.25%
21,279 $9.57 Million
Q2 2018

Jul 30, 2018

BUY
$278.07 - $446.21 $4.47 Million - $7.17 Million
16,064 Added 4016.0%
16,464 $6.73 Million
Q1 2018

Apr 26, 2018

SELL
$192.49 - $295.85 $946,088 - $1.45 Million
-4,915 Reduced 92.47%
400 $116,000
Q4 2017

Jan 10, 2018

BUY
$168.78 - $199.74 $139,749 - $165,384
828 Added 18.45%
5,315 $996,000
Q3 2017

Oct 25, 2017

BUY
$145.39 - $168.6 $652,364 - $756,508
4,487
4,487 $756,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.